The German Cancer Research Center (DKFZ) joins forces with the Research Institute for Translational Oncology (TRON gGmbH), the University Medical Center Mainz (UMC), and the Johannes Gutenberg University Mainz (JGU) to create a new institute.
- A Helmholtz-Institute of the DKFZ
- OUR INSTITUTE
- OUR MISSION
- OUR RESEARCH
The Helmholtz-Institute for Translational Oncology Mainz (HI-TRON Mainz) is a joint venture of the German Cancer Research Center (DKFZ) with the Research Institute for Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz (TRON gGmbH), the University Medical Center Mainz (UMC) and the Johannes Gutenberg University Mainz (JGU).
We aim to combine the internationally outstanding expertise of these partners in the field of personalized immunotherapy in Mainz with the comprehensive spectrum of cutting-edge cancer research at the DKFZ. HI-TRON Mainz strives to position itself among the world-leading centers for personalized cancer immuno-oncology.
An exciting event at HI-TRON Mainz.
The second HI-TRON Mainz Symposium took place on 16.02.2024.
About 110 invited guests of the HI-TRON partners joined in the insightful lectures and poster sessions
by the HI-TRON Mainz scientists and partners. A special highlight was the keynote lecture by
Johanna Olweus, a member of the HI-TRON Mainz Scientific Advisory Board, on TCR T cell therapies.
It was an engaging and inspiring day that focused on the joint fight against cancer.
Another visit at HI-TRON Mainz
Jens Jäger, the Delegate for the Research Field Health in the Helmholtz Association from Brussels
and Katja Großmann, the Representative for the Research Field Health
in the Helmholtz Association in Berlin visited HI-TRON Mainz.
- An exciting event at HI-TRON Mainz.
- Another visit at HI-TRON Mainz
- A new building for HI-TRON Mainz
- Clemens Hoch visits HI-TRON Mainz
Welcome Dr. Ibrahim Murathan Sektioglu
our new Senior Scientist in the Personalized Immunotherapies lab